MRNAModerna, Inc.

Nasdaq modernatx.com


$ 97.87 $ -7.13 (-6.79 %)    

Thursday, 01-Aug-2024 10:49:59 EDT
QQQ $ 467.18 $ -6.70 (-1.41 %)
DIA $ 404.74 $ -5.30 (-1.29 %)
SPY $ 547.42 $ -5.15 (-0.93 %)
TLT $ 95.82 $ 0.76 (0.8 %)
GLD $ 226.06 $ -0.76 (-0.34 %)
$ 119.22
$ 105.00
$ 90.00 x 146
$ 97.92 x 170
$ 94.51 - $ 105.00
$ 62.55 - $ 170.47
3,118,385
na
45.54B
$ 0.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 10-30-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-13-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 moderna-stock-sinks-on-lowered-2024-outlook-cites-low-european-sales-competitive-rsv-vaccine-market

Moderna's stock drops after cutting 2024 sales forecast due to reduced COVID-19 vaccine demand. The company now expects net...

Core News & Articles

- Conference Call

 moderna-revises-its-2024-expected-net-product-sales-to-3b-35b-from-its-respiratory-franchise-compared-to-prior-guidance-of-4b

For the second half of the year, it expects a sales split of 40-50% in the third quarter with the balance in the fourth quarter...

Core News & Articles

Directors Robert Langer and Stephen Berenson will also retire from the Board.

 covid-activity-is-elevated-across-26-states-in-summer-surge-biden-remains-in-isolation-3-vaccine-stocks-to-watch

Over half of US states have high levels of Covid-19 in wastewater as President Biden isolates with virus. New vaccines expected...

 european-commission-faces-court-criticism-over-covid-vaccine-contract-transparency-ahead-of-vote-on-ursula-von-der-leyens-reappointment

European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implication...

 health-officials-keep-close-eye-on-bird-flu-as-it-infects-cows-for-the-first-time

Avian influenza continues to spread among animals and has infected four dairy workers in the US. Concerns about human-to-human ...

 investor-that-backed-moderna-raises-36b-for-ai-driven-biotech-ventures

The funds are intended to launch a series of new biotech companies that will harness the power of generative artificial intelli...

 moderna-to-collaborate-with-mitsubishi-on-respiratory-vaccine-promotion-in-japan

Moderna and Mitsubishi signed a joint agreement regarding the co-promotion of Moderna's respiratory vaccine portfolio in Ja...

 reported-earlier-moderna-and-mitsubishi-tanabe-pharma-partner-to-promote-mrna-respiratory-vaccine-portfolio-in-japan

Under the agreement, Moderna will handle the manufacturing, sales, medical education and distribution of its mRNA respiratory v...

 ai-has-the-hallmarks-of-an-inflating-bubble-warns-veteran-wall-street-investor

Word to the wise: Ed Yardeni, in a July 4 note, warns his clients: "Too much capital can end even the best of parties."

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION